BBC Homepage World Service Education
BBC Homepagelow graphics version | feedback | help
BBC News Online
 You are in: Health
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Background Briefings 
Medical notes 
Education 
Entertainment 
Talking Point 
In Depth 
AudioVideo 

Thursday, 17 August, 2000, 23:37 GMT 00:37 UK
UK doctors in heart breakthrough
Surgery
Many heart surgery patients suffer side-effects
Doctors in London have identified a way of making heart surgery safer for patients.

Cardiac surgery is very complex and many patients suffer major complications after an operation.

But doctors at London's Hammersmith Hospital believe they have identified a drug which can be used to reduce the risks involved in heart surgery.

They have found that the drug aprotinin stops some of the body's unwanted and potentially damaging reactions to the operation.

The drug is currently used to cut down on bleeding during and after bypass surgery.


The use of aprotinin could become a standard procedure in heart operations across the world

Professor Ken Taylor, Hammersmith NHS Trust

But the doctors have suggested that administering the drug routinely to patients could have significant benefits for the hundreds of thousands of patients across the world who undergo heart surgery each year.

The research team, based at the British Heart Foundation Cardiovascular Unit within the hospital, discovered that aprotinin successfully stopped blood cells from becoming inflamed in a certain way.

This meant that the blood did not cause any of the body's other vital organs, such as the brain, lungs and kidneys, to react adversely to the surgical operation.

They also found that the drug could be used to prevent blood clotting, which is a major risk of heart surgery.

Professor Ken Taylor, BHF professor of cardiac surgery at Hammersmith NHS Trust said the use of the drug could become standard across the world as a way of reducing the side-effects of cardiac surgery.

"Our research clearly shows that the use of aprotinin could become a standard procedure in heart operations across the world.

"Many of our previous recommendations about the drug have become routine practice in cardiovascular surgery and we hope these important new findings will be adopted in a similar way."

He added: "The drug offers patients a better chance of avoiding the complications that can arise from complex cardiac surgery."

Search BBC News Online

Advanced search options
Launch console
BBC RADIO NEWS
BBC ONE TV NEWS
WORLD NEWS SUMMARY
PROGRAMMES GUIDE
See also:

06 Mar 00 | Health
Waiting in vain for heart surgery
Internet links:


The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.


E-mail this story to a friend

Links to more Health stories